[Corrigendum] miR‑23a suppresses pancreatic cancer cell progression by inhibiting PLK‑1 expression
Affiliations: Hepatopancreatobiliary Surgery Department, The Affiliated Hangzhou Hospital of Nanjing Medical University, Hangzhou, Zhejiang 310006, P.R. China, The Pancreas Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China, Thyroid Breast Surgery Department, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, Zhejiang 310014, P.R. China
- Published online on: May 17, 2022 https://doi.org/10.3892/mmr.2022.12738
- Article Number: 222
Copyright : © Chen et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
This article is mentioned in:
Mol Med Rep 18: [Related article:] 105–112, 2018; DOI: 10.3892/mmr.2018.8941
Subsequently to the publication of this paper, the authors have realized that they made an error during the sorting of the data panels shown for the migration and invasion assays shown in Fig. 2C; essentially, the ‘Invasion/PLL3.7’ panel was chosen from the same original data source as the panel selected to represent the ‘Migration/Inhibitor-NC’ experiment.
Effects of miR-23a on proliferation and metastasis ability of pancreatic cancer cells. Cell proliferation ability was examined in the Blank, inhibitor-NC, PLL 3.7, miR-23a and inhibitor groups after (A) 24 h and (B) 48 h treatment. (C) The migration and invasion cell number was stained with crystal violet and numbered in each group. Data were presented as the mean ± standard deviation. **P<0.01 vs. the blank group. NC, negative control; miR, microRNA.
The authors have consulted their original data, and realize that the ‘Invasion/PLL3.7’ data panel was inadvertently selected incorrectly for Fig. 2. The revised version of Fig. 2, showing the data appropriate for the ‘Invasion/PLL3.7’ experiment, is shown on the next page. Note that the errors made in assembling Fig. 2 did not significantly affect either the results or the conclusions reported in this paper, and all the authors agree to this Corrigendum. The authors are grateful to the Editor of Molecular Medicine Reports for allowing them the opportunity to publish this corrigendum, and apologize to the readership for any inconvenience caused.